123 related articles for article (PubMed ID: 32816795)
1. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials.
Riiser A; Stensrud T; Stang J; Andersen LB
Br J Sports Med; 2021 Sep; 55(17):975-983. PubMed ID: 32816795
[TBL] [Abstract][Full Text] [Related]
2. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
Riiser A; Stensrud T; Stang J; Andersen LB
Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
[TBL] [Abstract][Full Text] [Related]
3. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
[TBL] [Abstract][Full Text] [Related]
4. Beta₂-agonists for exercise-induced asthma.
Bonini M; Di Mambro C; Calderon MA; Compalati E; Schünemann H; Durham S; Canonica GW
Cochrane Database Syst Rev; 2013 Oct; (10):CD003564. PubMed ID: 24089311
[TBL] [Abstract][Full Text] [Related]
5. β2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis.
Singh B; Tiwari AK; Singh K; Singh SK; Ahmed A; Erwin PJ; Franco PM
Respir Care; 2014 Feb; 59(2):288-96. PubMed ID: 23777655
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
[TBL] [Abstract][Full Text] [Related]
7. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids and physical performance: A systematic review with meta-analysis of randomized controlled trials.
Riiser A; Stensrud T; Andersen LB
Front Sports Act Living; 2023; 5():1108062. PubMed ID: 37033881
[TBL] [Abstract][Full Text] [Related]
9. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
10. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
12. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
13. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
[TBL] [Abstract][Full Text] [Related]
14. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
15. Chronic Physiological Effects of Swim Training Interventions in Non-Elite Swimmers: A Systematic Review and Meta-Analysis.
Lahart IM; Metsios GS
Sports Med; 2018 Feb; 48(2):337-359. PubMed ID: 29086218
[TBL] [Abstract][Full Text] [Related]
16. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
17. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Jaeschke R; Schmidt S; Ferrer M
Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548
[TBL] [Abstract][Full Text] [Related]
18. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
[TBL] [Abstract][Full Text] [Related]
19. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis.
Becker LA; Hom J; Villasis-Keever M; van der Wouden JC
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD001726. PubMed ID: 26333656
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
